Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:39 pm Purchase | 2024-09-30 | 13G | Vincerx Pharma, Inc. VINC | Armistice Capital, LLC | 149,655 9.990% | 149,655 (New Position) | Filing History |
| 2024-11-14 11:57 am Sale | 2024-09-30 | 13G | Vincerx Pharma, Inc. VINC | BANK OF AMERICA CORP BAC | 482 0.000% | -53,662 (-99.11%) | Filing History |
| 2024-11-13 08:32 am Sale | 2024-09-30 | 13G | Vincerx Pharma, Inc. VINC | Prosight Management LP | 83,932 5.000% | -40,929 (-32.78%) | Filing History |
| 2024-05-03 09:00 am Purchase | 2024-04-25 | 13G | Vincerx Pharma, Inc. VINC | Prosight Management LP | 124,861 9.100% | 124,861 (New Position) | Filing History |
| 2024-04-09 5:09 pm Sale | 2024-03-28 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 31,575 3.000% | -53,908 (-63.06%) | Filing History |
| 2024-02-14 5:10 pm Sale | 2023-12-31 | 13G | Vincerx Pharma, Inc. VINC | LONG FOCUS CAPITAL MANAGEMENT, LLC | 54,938 5.100% | -15,810 (-22.35%) | Filing History |
| 2024-02-13 7:05 pm Purchase | 2023-12-31 | 13G | Vincerx Pharma, Inc. VINC | BANK OF AMERICA CORP BAC | 54,143 5.100% | 54,143 (New Position) | Filing History |
| 2024-02-13 4:55 pm Sale | 2023-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 0 0.000% | -74,639 (Position Closed) | Filing History |
| 2024-02-05 5:35 pm Sale | 2023-12-29 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 85,483 8.000% | -21,910 (-20.40%) | Filing History |
| 2023-02-14 4:03 pm Purchase | 2022-12-31 | 13G | Vincerx Pharma, Inc. VINC | LONG FOCUS CAPITAL MANAGEMENT, LLC | 70,748 6.700% | 70,748 (New Position) | Filing History |
| 2023-02-13 4:11 pm Purchase | 2022-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 74,639 7.040% | 17,870 (+31.48%) | Filing History |
| 2023-02-10 4:00 pm Sale | 2022-12-31 | 13G | Vincerx Pharma, Inc. VINC | Rubric Capital Management LP | 19,336 1.830% | -86,014 (-81.65%) | Filing History |
| 2023-02-10 1:46 pm Purchase | 2023-01-31 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 107,392 10.100% | 3,549 (+3.42%) | Filing History |
| 2023-02-08 09:53 am Purchase | 2022-12-30 | 13G | Vincerx Pharma, Inc. VINC | GOLDMAN SACHS GROUP INC GS | 103,844 9.800% | 103,844 (New Position) | Filing History |
| 2022-12-29 5:25 pm Sale | 2022-12-29 | 13G | Vincerx Pharma, Inc. VINC | James E. Flynn | 0 0.000% | -68,966 (Position Closed) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | TANG CAPITAL PARTNERS LP | 51,532 4.900% | 51,532 (New Position) | Filing History |
| 2022-02-14 11:22 am Unchanged | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | PUTNAM INVESTMENTS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 09:32 am Sale | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | RTW INVESTMENTS LP | 37,062 3.500% | -438 (-1.17%) | Filing History |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 56,768 5.390% | 2,957 (+5.50%) | Filing History |
| 2022-02-10 12:41 pm Purchase | 2022-01-31 | 13G | Vincerx Pharma, Inc. VINC | Rubric Capital Management LP | 105,350 10.006% | 105,350 (New Position) | Filing History |